1. Home
  2. TRX vs CTMX Comparison

TRX vs CTMX Comparison

Compare TRX & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRX
  • CTMX
  • Stock Information
  • Founded
  • TRX 1990
  • CTMX 2008
  • Country
  • TRX Canada
  • CTMX United States
  • Employees
  • TRX N/A
  • CTMX N/A
  • Industry
  • TRX
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRX
  • CTMX Health Care
  • Exchange
  • TRX Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • TRX 90.0M
  • CTMX 444.3M
  • IPO Year
  • TRX N/A
  • CTMX 2015
  • Fundamental
  • Price
  • TRX $0.32
  • CTMX $2.27
  • Analyst Decision
  • TRX Strong Buy
  • CTMX Strong Buy
  • Analyst Count
  • TRX 1
  • CTMX 2
  • Target Price
  • TRX $1.50
  • CTMX $5.00
  • AVG Volume (30 Days)
  • TRX 445.0K
  • CTMX 2.7M
  • Earning Date
  • TRX 07-22-2025
  • CTMX 08-07-2025
  • Dividend Yield
  • TRX N/A
  • CTMX N/A
  • EPS Growth
  • TRX N/A
  • CTMX 128.27
  • EPS
  • TRX N/A
  • CTMX 0.49
  • Revenue
  • TRX $45,405,000.00
  • CTMX $147,557,000.00
  • Revenue This Year
  • TRX $51.45
  • CTMX N/A
  • Revenue Next Year
  • TRX $26.19
  • CTMX N/A
  • P/E Ratio
  • TRX N/A
  • CTMX $4.78
  • Revenue Growth
  • TRX 26.50
  • CTMX 23.81
  • 52 Week Low
  • TRX $0.27
  • CTMX $0.40
  • 52 Week High
  • TRX $0.45
  • CTMX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • TRX 47.94
  • CTMX 50.77
  • Support Level
  • TRX $0.33
  • CTMX $2.08
  • Resistance Level
  • TRX $0.36
  • CTMX $2.44
  • Average True Range (ATR)
  • TRX 0.01
  • CTMX 0.24
  • MACD
  • TRX -0.00
  • CTMX -0.08
  • Stochastic Oscillator
  • TRX 3.54
  • CTMX 19.12

About TRX TRX Gold Corporation

TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: